title: Surveillance of resected non-small cell lung cancer.
abstract: Lung cancer is the most common cancer in the world. 15 % of all patients with lung cancer are diagnosed at an early stage, and surgery is the treatment of choice for them. 40 % of all patients survive more than 5 years after surgery, and most of them die as a result of systemic disease. Half of all recurrences are diagnosed within the first 24 months after curative treatment, and 90 % in the first 5 years. Despite this, it is not standardized who should do the monitoring, what additional tests are needed and how often should they be performed. We present here a review on the various recommendations in clinical guidelines.
authors.affiliation: Servicio Oncología Médica, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. alopgon2@hotmail.com
authors.forename: A
authors.initials: A
authors.lastname: López-González
authors.forename: P
authors.initials: P
authors.lastname: Ibeas Millán
authors.forename: B
authors.initials: B
authors.lastname: Cantos
authors.forename: M
authors.initials: M
authors.lastname: Provencio
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000601:surgery*; D019937:Diagnostic Techniques and Procedures / Q000706:statistics & numerical data; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000601:surgery*; D008495:Medical Oncology / Q000379:methods; D008991:Monitoring, Physiologic / Q000379:methods*; D017410:Practice Guidelines as Topic